SCHEMBL4185855

SCHEMBL4185855

CC(NCc1ccccc1NS(=O)(=O)c1ccc(-n2cccc2)cc1)[C@@H](O)C1CCCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 4/20 0.51
KDM4E B2RXH2 3/20 0.51
LMNA P02545 8/20 0.41
POLB P06746 5/20 0.41
ALDH1A1 P00352 9/20 0.39
MEN1 O00255 7/20 0.39
KMT2A Q03164 7/20 0.39
HSD17B10 Q99714 1/20 0.39
HPGD P15428 2/20 0.38
MAPT P10636 7/20 0.37
TDP1 Q9NUW8 2/20 0.37
BLM P54132 1/20 0.37
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 2/20 0.35
CASP1 P29466 1/20 0.35
HTT P42858 1/20 0.35
CASP7 P55210 1/20 0.35
TP53 P04637 2/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4188350 1.00 PKM (0.51) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL4185861 1.00 PKM (0.51) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL4188353 1.00 PKM (0.51) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL4189859 0.90 PKM (0.52) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL4192521 0.84 KDM4E (0.46) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL4192525 0.84 KDM4E (0.46) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL4202288 0.83 PKM (0.50) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL4201917 0.82 PKM (0.48) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL14343969 0.81 KDM4E (0.48) PKMKDM4ELMNAPOLBALDH1A1
SCHEMBL4190326 0.78 NPC1 (0.47) PKMKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 PKM 1855/4885KDM4E 3328/4885LMNA 2332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.